SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-15-005015
Filing Date
2015-06-11
Accepted
2015-06-11 08:55:46
Documents
6
Period of Report
2015-06-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20150610.htm 8-K 43126
2 EX-4.1 abio-ex41_2015061017.htm EX-4.1 91799
3 EX-4.2 abio-ex42_2015061018.htm EX-4.2 94400
4 EX-10.1 abio-ex101_2015061076.htm EX-10.1 627909
5 EX-99.1 abio-ex991_2015061019.htm EX-99.1 12450
6 GRAPHIC g201506111146252821606.jpg GRAPHIC 216495
  Complete submission text file 0001564590-15-005015.txt   1169516
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 15924911
SIC: 2835 In Vitro & In Vivo Diagnostic Substances